[Tumor markers p53, sFAS, FASL, CEA and CA 19-9 in evaluating the effectiveness of surgical and pharmaco nutritional treatment of patients with gastric cancer].

Ėksperimental'nai{combining double inverted breve}a i klinicheskai{combining double inverted breve}a gastroėnterologii{combining double inverted breve}a = Experimental & clinical gastroenterology

Volumn , Issue 2, 2012, Pages 41-49

  Bluvshtein G A ^a   Lysenko, V G ^a   Zakharova, N B ^a   Kitaev, I V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; PARENTERAL SOLUTION; PROTEIN P53; TUMOR MARKER;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PREDICTIVE VALUE; STOMACH TUMOR;

AGED; ANTIGENS, CD95; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION SOLUTIONS; PREDICTIVE VALUE OF TESTS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84864877813     PISSN: 16828658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)